No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use*
-
Base Sequence
-
Benzamides
-
Chronic Disease
-
Drug Resistance, Neoplasm* / genetics
-
Humans
-
Hypereosinophilic Syndrome / drug therapy*
-
Hypereosinophilic Syndrome / immunology*
-
Hypereosinophilic Syndrome / metabolism
-
Imatinib Mesylate
-
Male
-
Middle Aged
-
Molecular Sequence Data
-
Piperazines / administration & dosage*
-
Pyrimidines / administration & dosage*
-
Receptor, Platelet-Derived Growth Factor alpha / biosynthesis*
-
Receptor, Platelet-Derived Growth Factor alpha / genetics
-
Recombinant Fusion Proteins / genetics
-
Recombinant Fusion Proteins / physiology*
-
mRNA Cleavage and Polyadenylation Factors / biosynthesis*
-
mRNA Cleavage and Polyadenylation Factors / genetics
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Benzamides
-
FIP1L1 protein, human
-
Piperazines
-
Pyrimidines
-
Recombinant Fusion Proteins
-
mRNA Cleavage and Polyadenylation Factors
-
Imatinib Mesylate
-
mepolizumab
-
Receptor, Platelet-Derived Growth Factor alpha